Cargando…
Endocannabinoid System in Hepatic Glucose Metabolism, Fatty Liver Disease, and Cirrhosis
There is growing evidence that glucose metabolism in the liver is in part under the control of the endocannabinoid system (ECS) which is also supported by its presence in this organ. The ECS consists of its cannabinoid receptors (CBRs) and enzymes that are responsible for endocannabinoid production...
Autores principales: | Bazwinsky-Wutschke, Ivonne, Zipprich, Alexander, Dehghani, Faramarz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6566399/ https://www.ncbi.nlm.nih.gov/pubmed/31121839 http://dx.doi.org/10.3390/ijms20102516 |
Ejemplares similares
-
Daytime-Dependent Changes of Cannabinoid Receptor Type 1 and Type 2 Expression in Rat Liver
por: Bazwinsky-Wutschke, Ivonne, et al.
Publicado: (2017) -
Influence of Cannabinoid Receptor Deficiency on Parameters Involved in Blood Glucose Regulation in Mice
por: Zibolka, Juliane, et al.
Publicado: (2020) -
The Role of Endocannabinoids System in Fatty Liver Disease and Therapeutic Potentials
por: Alswat, Khalid A.
Publicado: (2013) -
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with Widespread Physiological and Pharmacological Activities
por: Grabiec, Urszula, et al.
Publicado: (2017) -
Central Endocannabinoid Signaling Regulates Hepatic Glucose Production and Systemic Lipolysis
por: O’Hare, James D., et al.
Publicado: (2011)